Use of capillary ketones monitoring in treatment of mild ketotic crisis in people with ketosis-prone atypical diabetes

J Investig Med. 2020 Aug;68(6):1193-1195. doi: 10.1136/jim-2019-001267. Epub 2020 Jul 14.

Abstract

This study was carried out to assess the potential reduction in duration of intensive diabetic ketoacidosis treatment in adults with ketosis-prone atypical diabetes (KPD) when using capillary versus urinary ketones. In this cross-sectional study, we included 20 people with KPD presented at the National Obesity Center of the Yaoundé Central Hospital with hyperglycemic decompensation (random capillary glucose ≥13 mmol/L) and significant ketosis (ketonuria≥++) requiring intensive insulin treatment. In all subjects, intensive insulin treatment was initiated at 10 UI per hour with simultaneous measurement of capillary beta-hydroxybutyrate and ketonuria every 2 hours until disappearance of ketonuria. Time-to-disappearance of urine ketones was compared with the time-to-normalization of capillary β-hydroxybutyrate concentrations. Subjects were aged 46±13 years with a median duration of diabetes of 1.5 (IQR: 0-2.5) years. On admission, the mean blood glucose was 22.8±5 mmol/L and capillary ketones level was 2.9±2.7 mmol/L. The median time-to-disappearance of ketonuria was 5 (IQR: 3-8) hours compared with the time-to-normalization of capillary β-hydroxybutyrate of 4 (IQR: 2-6) hours, p=0.0002. The absolute difference in time-to-normalization of ketonuria versus ketonemia was 2 (IQR: 1-3) hours and the relative time reduction of treatment was 32.5%±18.0%. Our results suggested that the use of capillary ketones versus ketonuria would allow a significant reduction in duration of intensive insulin treatment by one third in people with KPD.

Keywords: diabetes complications; diabetes mellitus; disease management.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Capillaries
  • Diabetes Mellitus, Type 1 / complications
  • Diabetic Ketoacidosis / blood*
  • Diabetic Ketoacidosis / diagnosis
  • Diabetic Ketoacidosis / drug therapy
  • Diabetic Ketoacidosis / urine
  • Female
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Insulin / therapeutic use
  • Kaplan-Meier Estimate
  • Ketones / blood*
  • Ketones / urine
  • Male
  • Middle Aged
  • Time-to-Treatment

Substances

  • Hypoglycemic Agents
  • Insulin
  • Ketones